# Longevity Science vs. Hype | Brian Kennedy, Ph.D.

**Channel:** Peter Attia MD
**Upload Date:** 2025-07-25
**URL:** https://www.youtube.com/watch?v=acBTr0KkRnE
**Duration:** 7 minutes

## Description

Get An Introductory Guide to Longevity and my weekly newsletter here (free): https://bit.ly/4kPNmQL
Watch the full episode: https://youtu.be/7yNvz_0Q1eQ
Become a member to receive exclusive content: https://bit.ly/3IEFjIV

This clip is from episode #357 ‒ A new era of longevity science: models of aging, human trials of rapamycin, biological clocks, promising compounds, and lifestyle interventions | Brian Kennedy, Ph.D.

In this clip, they discuss:

- Concerns Around Gene Therapy – While gene therapy is promising, it’s still early-stage, and the long-term data isn’t there yet to justify its cost or use
- Stem Cell Use: Potential & Pitfalls – Stem cells may help with injury repair, but there are major concerns about practitioner quality and safety standards in certain clinics
- Lack of Long-Term Data – Clinical trials on longevity therapies are limited by the need for long observation periods
- The Need for Better Oversight – The conversation highlights how hard it is for consumers to distinguish between reputable and dangerous clinics offering longevity interventions
- The Role of Scientists in Oversight – There’s a tension between academic researchers and longevity clinics, but collaboration may offer safer outcomes than isolation

--------
About:

The Peter Attia Drive is a deep-dive podcast focusing on maximizing longevity, and all that goes into that from physical to cognitive to emotional health. With over 90 million episodes downloaded, it features topics including exercise, nutritional biochemistry, cardiovascular disease, Alzheimer’s disease, cancer, mental health, and much more.

Peter Attia is the founder of Early Medical, a medical practice that applies the principles of Medicine 3.0 to patients with the goal of lengthening their lifespan and simultaneously improving their healthspan. 

Learn more: https://peterattiamd.com

Connect with Peter on:
Facebook: http://bit.ly/PeterAttiaMDFB
Twitter: http://bit.ly/PeterAttiaMDTW
Instagram: http://bit.ly/PeterAttiaMDIG

Subscribe to The Drive:
Apple Podcast: http://bit.ly/TheDriveApplePodcasts
Overcast: http://bit.ly/TheDriveOvercast
Spotify: http://bit.ly/TheDriveSpotify
Google Podcasts: http://bit.ly/TheDriveGoogle

Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed. The use of this information and the materials linked to this podcast is at the user's own risk. The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions. I take conflicts of interest very seriously. For all of my disclosures and the companies I invest in or advise, please visit my website where I keep an up-to-date and active list of such companies. For a full list of our registered and unregistered trademarks, trade names, and service marks, please review our Terms of Use: https://peterattiamd.com/terms-of-use/

## AI Summary

Here's my analysis of this clip from The Drive podcast with Brian Kennedy:

1. **Executive Summary**:
This segment focuses on concerns in the longevity and biohacking space, particularly regarding unproven treatments and safety issues. Dr. Kennedy and Dr. Attia discuss various interventions like gene therapy, stem cells, and growth hormone, weighing their potential benefits against safety concerns. They emphasize the importance of careful consideration and proper medical oversight when pursuing longevity interventions.

2. **Key Medical/Scientific Points**:
- Discussion of Follistatin gene therapy and its current unproven status [00:00:00]
- Mesenchymal stem cell (MSC) treatments and their varying efficacy for different conditions [00:00:52]
- Growth hormone considerations and cancer risk discussion [00:01:34]
- Rapamycin use in geroprotective applications [00:03:31]
- SGLT2 inhibitors in non-diabetic patients mentioned [00:03:31]

3. **Health Optimization Tips**:
Universal Recommendations:
- Exercise caution with unproven treatments [00:00:00]
- Seek qualified practitioners for any interventions [00:00:52]

Risk/Benefit Considerations:
- Growth hormone benefits vs. potential cancer risk [00:01:34]
- Stem cell therapy safety depends heavily on practitioner quality [00:00:52]

4. **Supplements & Medications**:
Medications mentioned:
- Rapamycin (for geroprotection) [00:03:31]
- SGLT2 inhibitors [00:03:31]
- Growth hormone [00:01:34]

5. **Notable Quotes**:
"I've never spoken to a person who takes a modest judicious dose of growth hormone who doesn't tell me they feel better." - Dr. Attia [00:01:34]

"I think if you're going to go do that stuff, you need to go in with your eyes open. You're taking a risk." - Dr. Kennedy [00:03:31]

6. **Follow-up Questions**:
1. What are the specific safety protocols for stem cell treatments?
2. How can we better study long-term effects of growth hormone use?
3. What metrics should be used to evaluate longevity clinic legitimacy?
4. What is the optimal protocol for rapamycin use in healthy individuals?

The clip ends at [00:07:51], but focuses mainly on the discussion of various longevity interventions and their associated risks. Would you like me to elaborate on any particular aspect of this analysis?
